Clinical Report: Building Better Oral Suspensions for Pediatric Use
Overview
This report discusses the challenges and innovations in developing oral suspensions for pediatric patients, particularly focusing on the Vyscoxa project aimed at creating a liquid dosage form for juvenile rheumatoid arthritis. The need for palatable and stable formulations is emphasized, alongside the importance of novel excipients in overcoming formulation hurdles.
Background
The development of pediatric medications poses unique challenges, particularly in ensuring that formulations are safe, effective, and acceptable for younger patients. Oral suspensions are often preferred for children who cannot swallow tablets, yet they face issues related to taste, stability, and bioavailability. Addressing these challenges is crucial for improving access to necessary therapies for underserved pediatric populations.
Data Highlights
No numerical data available in the source material.
Key Findings
Rephrase findings for clarity and ensure they are directly supported by the source.Clinical Implications
Healthcare professionals should be aware of the specific formulation needs of pediatric patients, particularly regarding oral suspensions. Emphasizing palatability and stability can enhance adherence and therapeutic outcomes in this population.
Conclusion
The development of effective oral suspensions for pediatric use is critical for improving treatment access and adherence. Continued innovation in formulation science, including the use of novel excipients, is essential to meet the unique needs of young patients.
References
- Greg Thomas, Kiel Laboratories, 2023 -- Building Better Oral Suspensions for Pediatric & Real-World Use
- inside dentistry — Modern Solutions for Biofilm Management and Fluoride-Free Remineralization
- Bone Marrow Transplantation — The 50th Annual Conference of the European Society for Blood and Marrow Transplantation: Oral Presentations by the Pharmacist Committee (Sessions O155-O159)
- Drugs - Real World Outcomes — Evaluating Pediatric Medication Safety and Effectiveness Through Real-World Evidence: A Systematic Review
- American Journal of Epidemiology — Assessing the Appeal of Outcome Ranking and Response Adjusted for Antibiotic Duration Risk in Pediatric Pneumonia Clinical Trials
- E11A Pediatric Extrapolation | FDA
- Evaluating Pediatric Medication Safety and Effectiveness Through Real-World Evidence: A Systematic Review
- Accuracy of liquid drug dose measurements using different tools by caregivers: a prospective observational study - PubMed
- A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
